Delivery Order SPE2DB24D3013-SPE2DB25FFPCF
- Not listed
- On July 25, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $3,130.06 to AmerisourceBergen Drug Corp for the supply of Quillichew ER 30 mg chewable tablets (100-count units). This firm fixed-price delivery order, with an ultimate completion date of July 28, 2025, is issued under a non-set-aside competitive procurement and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical products will be delivered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Quillichew ER 20 mg chew tablets (100-count units) with a ceiling value of $1,043.96. This competitively awarded, firm fixed-price delivery order is not set-aside and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,088.72 to AmerisourceBergen Drug Corp for Quillichew ER Chew Tabs 40mg, a medication commonly used to treat attention-deficit/hyperactivity disorder. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,271.33 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Quillichew ER 30 mg chew tablets (100-count units). This non-set-aside competitive award will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,020.06 to AmerisourceBergen Drug Corp for Quillichew ER 30 mg chewable tablets (100 count) on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract employs firm fixed price terms and is classified as a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,009 to Amerisourcebergen Drug Corporation to provide 100 units of 20mg Quillichew ER chewable tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by August 30, 2023 under the terms of the contract. The Defense Logistics Agency is the funding agency for this delivery order placed against an...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 20 mg QUILLICHEW ER chewable tablets in quantities of 100s. The firm-fixed-price contract has a ceiling value of $5,222.76 and a period of performance through May 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $906 to Amerisourcebergen Drug Corporation to provide 100 units of 20mg Quillichew ER chewable tablets. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania under a one day period of performance from July 12 to July 13, 2023. The Defense Logistics Agency routinely issues delivery orders against various...
- The Defense Logistics Agency Troop Support Medical awarded a $1,813.58 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 units of 20 mg Quillichew ER chewable tablets. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products and services in support of Department of Defense health care programs. Performance will take place in Conshohocken, Pennsylvania over a period of one day from July 20, 2023...
- The Defense Logistics Agency awarded a $2,689 delivery order contract to Amerisourcebergen Drug Corporation for the supply of 4,562,179,140 Quillichew ER 30 mg chew tablets. The firm fixed price contract calls for the delivery of 100 boxes of the specified pharmaceutical product to a location in Conshohocken, Pennsylvania by September 15, 2023. Amerisourcebergen will perform as the prime contractor, with the Defense Logistics Agency serving as the contracting agency. No additional details were...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFPCFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Quillichew ER 40 mg chew tablets (100-count units) with a ceiling value of $1,341.21. This is a firm fixed price delivery order executed under a non-competitive set-aside structure, with performance to be completed by August 8, 2025, and fulfillment from the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a substantial federal contract portfolio primarily with the Defense Logistics Agency's Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. This delivery order for ADHD medication supports the agency's ongoing efforts to ensure adequate pharmaceutical inventory for military healthcare programs worldwide through a flexible and comprehensive contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/7/25 |